Nextremity Solutions’ Arcus Staple System receives FDA approval: 4 quick facts

Nextremity Solutions received FDA 510(k) approval to market its upcoming Arcus Staple System.

Advertisement

Here are four quick facts:

 

1. The staple system is indicated for fixation of bone fractures, bone reconstruction, ligament, soft tissue and tendon.

 

2. According to Ryan Schlotterback, director of product development, testing has shown that the Arcus system better maintains compression over time when compared to the competition.  

 

3. Nextremity Solutions’ application for a CE mark is pending.

 

4. Nextremity Solutions is a privately held medical device company focusing on solutions for foot and ankle surgical intervention.

 

More articles on devices:
7 key notes on Medtronic’s Q1: CEO Omar Ishrak’s take
Electrostimulation implant to help idiopathic scoliosis: 6 things to know
4 recent spine, orthopedic device company mergers & acquisitions

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.